Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02110082
Title Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

head and neck squamous cell carcinoma

Therapies

Cetuximab + Urelumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Stanford California 94305 United States Details
University Of Chicago Chicago Illinois 60637 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Providence Oncology & Hematology Care Eastside Portland Oregon 97213 United States Details
Upmc Cancer Center Pittsburgh Pennsylvania 15213 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field